![Dominik Höchli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dominik Höchli
Directeur/Bestuurslid bij
MOLECULAR PARTNERS AG
Vermogen: 19 331 $ op 30-06-2026
Profiel
Dominik Höchli is currently an Independent Non-Executive Director at Molecular Partners AG since 2021 and an Independent Director at Abivax SA starting in 2025.
Formerly, Dr. Höchli was Co-Managing Director at Catapult Therapeutics BV from 2021 to 2025 and Vice President & Head-Global Medical Affairs at AbbVie AG.
Education includes a doctorate from the University of Bern.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2025 | 4.982 ( 0,01% ) | 19 331 $ | 30-06-2026 |
Actieve functies van Dominik Höchli
| Bedrijven | Functie | Begin |
|---|---|---|
| MOLECULAR PARTNERS AG | Directeur/Bestuurslid | 21-04-2021 |
| ABIVAX | Directeur/Bestuurslid | 22-04-2025 |
Eerdere bekende functies van Dominik Höchli
| Bedrijven | Functie | Einde |
|---|---|---|
Catapult Therapeutics BV
 Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company which develops cancer treatments | Algemeen Directeur | 22-04-2025 |
AbbVie AG
 AbbVie AG Miscellaneous Commercial ServicesCommercial Services Develops and markets therapies | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Dominik Höchli
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
49
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of Bern
 University of Bern Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
AbbVie AG
AbbVie AG Miscellaneous Commercial ServicesCommercial Services Develops and markets therapies | Commercial Services |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company which develops cancer treatments | Commercial Services |
